Importance of endogenous adenosine during ischemia and reperfusion in neonatal porcine hearts
Adenosine has several potentially cardioprotective effects. We hypothesized that the effects of endogenous adenosine vary with degree of ischemia and that elevating endogenous levels is protective. Isolated blood-perfused piglet hearts underwent 120 minutes of low-flow ischemia (10% flow) or 90 minu...
Gespeichert in:
| Veröffentlicht in: | Circulation (New York, N.Y.) N.Y.), 1997-11, Vol.96 (9), p.3094-3103 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 3103 |
|---|---|
| container_issue | 9 |
| container_start_page | 3094 |
| container_title | Circulation (New York, N.Y.) |
| container_volume | 96 |
| creator | SOMMERSCHILD, H. T GRUND, F OFFSTAD, J JYNGE, P ILEBEKK, A KIRKEBØEN, K. A |
| description | Adenosine has several potentially cardioprotective effects. We hypothesized that the effects of endogenous adenosine vary with degree of ischemia and that elevating endogenous levels is protective.
Isolated blood-perfused piglet hearts underwent 120 minutes of low-flow ischemia (10% flow) or 90 minutes of zero-flow ischemia, all with 60 minutes of reperfusion. Hearts were treated with either saline, the adenosine receptor blocker 8-sulfophenyltheophylline (8SPT, 300 micromol x L(-1)), or the nucleoside transport inhibitor draflazine (1 micromol x L(-1)). In separate groups, biopsies were obtained before and at the end of ischemia. Compared with saline, 8SPT did not significantly alter functional recovery in either protocol. Draflazine significantly improved percent recovery of left ventricular systolic pressure both in the low-flow protocol (92+/-3% versus 75+/-2% [saline] and 73+/-3% [8SPT], P |
| doi_str_mv | 10.1161/01.CIR.96.9.3094 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79439540</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79439540</sourcerecordid><originalsourceid>FETCH-LOGICAL-c391t-9d566bcdfaa86ac4c9eb4fa78fa2ffbd6e11977b756babb8106d70371dcbb5e03</originalsourceid><addsrcrecordid>eNpdkM1r3DAUxEVpSbZJ7r0ERAm92dGHLVnHsKTtQqAQ0mMRT1-Jgy1tJPuQ_z5asuTQ0_B4vxmGQegbJS2lgl4T2m53960SrWo5Ud0ntKE965qu5-oz2hBCVCM5Y6foaynP9RRc9ifoRPFB0IFs0L_dvE95gWg9TgH76NKjj2ktGFzVMkaP3ZrH-IjHYp_8PAKG6HD2e5_DWsYU8Rhx9CnCAhOuYfbgefKQl3KOvgSYir846hn6-_P2Yfu7ufvza7e9uWssV3RplOuFMNYFgEGA7azypgsghwAsBOOEp1RJaWQvDBgzUCKcJFxSZ43pPeFn6Md77j6nl9WXRc-1rZ8mqMXWoqXquOq7A_j9P_A5rTnWbppRJhnjtKsQeYdsTqVkH_Q-jzPkV02JPsyuCdV1dq2EVvowe7VcHnNXM3v3YTjuXP9Xxz8UC1PIdfCxfGCMCNLXmDe4YYxR</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>212722314</pqid></control><display><type>article</type><title>Importance of endogenous adenosine during ischemia and reperfusion in neonatal porcine hearts</title><source>MEDLINE</source><source>American Heart Association Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Journals@Ovid Complete</source><creator>SOMMERSCHILD, H. T ; GRUND, F ; OFFSTAD, J ; JYNGE, P ; ILEBEKK, A ; KIRKEBØEN, K. A</creator><creatorcontrib>SOMMERSCHILD, H. T ; GRUND, F ; OFFSTAD, J ; JYNGE, P ; ILEBEKK, A ; KIRKEBØEN, K. A</creatorcontrib><description>Adenosine has several potentially cardioprotective effects. We hypothesized that the effects of endogenous adenosine vary with degree of ischemia and that elevating endogenous levels is protective.
Isolated blood-perfused piglet hearts underwent 120 minutes of low-flow ischemia (10% flow) or 90 minutes of zero-flow ischemia, all with 60 minutes of reperfusion. Hearts were treated with either saline, the adenosine receptor blocker 8-sulfophenyltheophylline (8SPT, 300 micromol x L(-1)), or the nucleoside transport inhibitor draflazine (1 micromol x L(-1)). In separate groups, biopsies were obtained before and at the end of ischemia. Compared with saline, 8SPT did not significantly alter functional recovery in either protocol. Draflazine significantly improved percent recovery of left ventricular systolic pressure both in the low-flow protocol (92+/-3% versus 75+/-2% [saline] and 73+/-3% [8SPT], P<.001 for both) and in the zero-flow protocol (76+/-3% versus 59+/-4% [saline] and 46+/-9% [8SPT], P<.05 for both). In the zero-flow protocol, draflazine also significantly reduced ischemic contracture and release of creatine kinase. Tissue adenosine at the end of ischemia was elevated by draflazine compared with saline-treated hearts: after low-flow ischemia to 0.10+/-0.05 versus 0.00+/-0.00 micromol x g(-1) dry wt (P<.05) and after zero-flow ischemia to 1.73+/-0.82 versus 0.15+/-0.03 micromol x g(-1) dry wt (P<.05).
In neonatal porcine hearts, endogenous adenosine produced during ischemia does not influence ischemic injury or functional recovery. Elevating endogenous adenosine by draflazine elicits cardioprotection in both low-flow and zero-flow conditions.</description><identifier>ISSN: 0009-7322</identifier><identifier>EISSN: 1524-4539</identifier><identifier>DOI: 10.1161/01.CIR.96.9.3094</identifier><identifier>PMID: 9386180</identifier><identifier>CODEN: CIRCAZ</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams & Wilkins</publisher><subject>Adenosine - physiology ; Animals ; Animals, Newborn ; Biological and medical sciences ; Cardiology. Vascular system ; Coronary heart disease ; Creatine Kinase - metabolism ; Heart ; Medical sciences ; Myocardial Contraction ; Myocardial Ischemia - physiopathology ; Myocardial Reperfusion ; Piperazines - pharmacology ; Swine ; Theophylline - analogs & derivatives ; Theophylline - pharmacology</subject><ispartof>Circulation (New York, N.Y.), 1997-11, Vol.96 (9), p.3094-3103</ispartof><rights>1998 INIST-CNRS</rights><rights>Copyright American Heart Association, Inc. Nov 4, 1997</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c391t-9d566bcdfaa86ac4c9eb4fa78fa2ffbd6e11977b756babb8106d70371dcbb5e03</citedby><cites>FETCH-LOGICAL-c391t-9d566bcdfaa86ac4c9eb4fa78fa2ffbd6e11977b756babb8106d70371dcbb5e03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,3687,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2060594$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9386180$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SOMMERSCHILD, H. T</creatorcontrib><creatorcontrib>GRUND, F</creatorcontrib><creatorcontrib>OFFSTAD, J</creatorcontrib><creatorcontrib>JYNGE, P</creatorcontrib><creatorcontrib>ILEBEKK, A</creatorcontrib><creatorcontrib>KIRKEBØEN, K. A</creatorcontrib><title>Importance of endogenous adenosine during ischemia and reperfusion in neonatal porcine hearts</title><title>Circulation (New York, N.Y.)</title><addtitle>Circulation</addtitle><description>Adenosine has several potentially cardioprotective effects. We hypothesized that the effects of endogenous adenosine vary with degree of ischemia and that elevating endogenous levels is protective.
Isolated blood-perfused piglet hearts underwent 120 minutes of low-flow ischemia (10% flow) or 90 minutes of zero-flow ischemia, all with 60 minutes of reperfusion. Hearts were treated with either saline, the adenosine receptor blocker 8-sulfophenyltheophylline (8SPT, 300 micromol x L(-1)), or the nucleoside transport inhibitor draflazine (1 micromol x L(-1)). In separate groups, biopsies were obtained before and at the end of ischemia. Compared with saline, 8SPT did not significantly alter functional recovery in either protocol. Draflazine significantly improved percent recovery of left ventricular systolic pressure both in the low-flow protocol (92+/-3% versus 75+/-2% [saline] and 73+/-3% [8SPT], P<.001 for both) and in the zero-flow protocol (76+/-3% versus 59+/-4% [saline] and 46+/-9% [8SPT], P<.05 for both). In the zero-flow protocol, draflazine also significantly reduced ischemic contracture and release of creatine kinase. Tissue adenosine at the end of ischemia was elevated by draflazine compared with saline-treated hearts: after low-flow ischemia to 0.10+/-0.05 versus 0.00+/-0.00 micromol x g(-1) dry wt (P<.05) and after zero-flow ischemia to 1.73+/-0.82 versus 0.15+/-0.03 micromol x g(-1) dry wt (P<.05).
In neonatal porcine hearts, endogenous adenosine produced during ischemia does not influence ischemic injury or functional recovery. Elevating endogenous adenosine by draflazine elicits cardioprotection in both low-flow and zero-flow conditions.</description><subject>Adenosine - physiology</subject><subject>Animals</subject><subject>Animals, Newborn</subject><subject>Biological and medical sciences</subject><subject>Cardiology. Vascular system</subject><subject>Coronary heart disease</subject><subject>Creatine Kinase - metabolism</subject><subject>Heart</subject><subject>Medical sciences</subject><subject>Myocardial Contraction</subject><subject>Myocardial Ischemia - physiopathology</subject><subject>Myocardial Reperfusion</subject><subject>Piperazines - pharmacology</subject><subject>Swine</subject><subject>Theophylline - analogs & derivatives</subject><subject>Theophylline - pharmacology</subject><issn>0009-7322</issn><issn>1524-4539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkM1r3DAUxEVpSbZJ7r0ERAm92dGHLVnHsKTtQqAQ0mMRT1-Jgy1tJPuQ_z5asuTQ0_B4vxmGQegbJS2lgl4T2m53960SrWo5Ud0ntKE965qu5-oz2hBCVCM5Y6foaynP9RRc9ifoRPFB0IFs0L_dvE95gWg9TgH76NKjj2ktGFzVMkaP3ZrH-IjHYp_8PAKG6HD2e5_DWsYU8Rhx9CnCAhOuYfbgefKQl3KOvgSYir846hn6-_P2Yfu7ufvza7e9uWssV3RplOuFMNYFgEGA7azypgsghwAsBOOEp1RJaWQvDBgzUCKcJFxSZ43pPeFn6Md77j6nl9WXRc-1rZ8mqMXWoqXquOq7A_j9P_A5rTnWbppRJhnjtKsQeYdsTqVkH_Q-jzPkV02JPsyuCdV1dq2EVvowe7VcHnNXM3v3YTjuXP9Xxz8UC1PIdfCxfGCMCNLXmDe4YYxR</recordid><startdate>19971104</startdate><enddate>19971104</enddate><creator>SOMMERSCHILD, H. T</creator><creator>GRUND, F</creator><creator>OFFSTAD, J</creator><creator>JYNGE, P</creator><creator>ILEBEKK, A</creator><creator>KIRKEBØEN, K. A</creator><general>Lippincott Williams & Wilkins</general><general>American Heart Association, Inc</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>U9A</scope><scope>7X8</scope></search><sort><creationdate>19971104</creationdate><title>Importance of endogenous adenosine during ischemia and reperfusion in neonatal porcine hearts</title><author>SOMMERSCHILD, H. T ; GRUND, F ; OFFSTAD, J ; JYNGE, P ; ILEBEKK, A ; KIRKEBØEN, K. A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c391t-9d566bcdfaa86ac4c9eb4fa78fa2ffbd6e11977b756babb8106d70371dcbb5e03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Adenosine - physiology</topic><topic>Animals</topic><topic>Animals, Newborn</topic><topic>Biological and medical sciences</topic><topic>Cardiology. Vascular system</topic><topic>Coronary heart disease</topic><topic>Creatine Kinase - metabolism</topic><topic>Heart</topic><topic>Medical sciences</topic><topic>Myocardial Contraction</topic><topic>Myocardial Ischemia - physiopathology</topic><topic>Myocardial Reperfusion</topic><topic>Piperazines - pharmacology</topic><topic>Swine</topic><topic>Theophylline - analogs & derivatives</topic><topic>Theophylline - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SOMMERSCHILD, H. T</creatorcontrib><creatorcontrib>GRUND, F</creatorcontrib><creatorcontrib>OFFSTAD, J</creatorcontrib><creatorcontrib>JYNGE, P</creatorcontrib><creatorcontrib>ILEBEKK, A</creatorcontrib><creatorcontrib>KIRKEBØEN, K. A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Circulation (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SOMMERSCHILD, H. T</au><au>GRUND, F</au><au>OFFSTAD, J</au><au>JYNGE, P</au><au>ILEBEKK, A</au><au>KIRKEBØEN, K. A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Importance of endogenous adenosine during ischemia and reperfusion in neonatal porcine hearts</atitle><jtitle>Circulation (New York, N.Y.)</jtitle><addtitle>Circulation</addtitle><date>1997-11-04</date><risdate>1997</risdate><volume>96</volume><issue>9</issue><spage>3094</spage><epage>3103</epage><pages>3094-3103</pages><issn>0009-7322</issn><eissn>1524-4539</eissn><coden>CIRCAZ</coden><abstract>Adenosine has several potentially cardioprotective effects. We hypothesized that the effects of endogenous adenosine vary with degree of ischemia and that elevating endogenous levels is protective.
Isolated blood-perfused piglet hearts underwent 120 minutes of low-flow ischemia (10% flow) or 90 minutes of zero-flow ischemia, all with 60 minutes of reperfusion. Hearts were treated with either saline, the adenosine receptor blocker 8-sulfophenyltheophylline (8SPT, 300 micromol x L(-1)), or the nucleoside transport inhibitor draflazine (1 micromol x L(-1)). In separate groups, biopsies were obtained before and at the end of ischemia. Compared with saline, 8SPT did not significantly alter functional recovery in either protocol. Draflazine significantly improved percent recovery of left ventricular systolic pressure both in the low-flow protocol (92+/-3% versus 75+/-2% [saline] and 73+/-3% [8SPT], P<.001 for both) and in the zero-flow protocol (76+/-3% versus 59+/-4% [saline] and 46+/-9% [8SPT], P<.05 for both). In the zero-flow protocol, draflazine also significantly reduced ischemic contracture and release of creatine kinase. Tissue adenosine at the end of ischemia was elevated by draflazine compared with saline-treated hearts: after low-flow ischemia to 0.10+/-0.05 versus 0.00+/-0.00 micromol x g(-1) dry wt (P<.05) and after zero-flow ischemia to 1.73+/-0.82 versus 0.15+/-0.03 micromol x g(-1) dry wt (P<.05).
In neonatal porcine hearts, endogenous adenosine produced during ischemia does not influence ischemic injury or functional recovery. Elevating endogenous adenosine by draflazine elicits cardioprotection in both low-flow and zero-flow conditions.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams & Wilkins</pub><pmid>9386180</pmid><doi>10.1161/01.CIR.96.9.3094</doi><tpages>10</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0009-7322 |
| ispartof | Circulation (New York, N.Y.), 1997-11, Vol.96 (9), p.3094-3103 |
| issn | 0009-7322 1524-4539 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_79439540 |
| source | MEDLINE; American Heart Association Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Journals@Ovid Complete |
| subjects | Adenosine - physiology Animals Animals, Newborn Biological and medical sciences Cardiology. Vascular system Coronary heart disease Creatine Kinase - metabolism Heart Medical sciences Myocardial Contraction Myocardial Ischemia - physiopathology Myocardial Reperfusion Piperazines - pharmacology Swine Theophylline - analogs & derivatives Theophylline - pharmacology |
| title | Importance of endogenous adenosine during ischemia and reperfusion in neonatal porcine hearts |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T21%3A00%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Importance%20of%20endogenous%20adenosine%20during%20ischemia%20and%20reperfusion%20in%20neonatal%20porcine%20hearts&rft.jtitle=Circulation%20(New%20York,%20N.Y.)&rft.au=SOMMERSCHILD,%20H.%20T&rft.date=1997-11-04&rft.volume=96&rft.issue=9&rft.spage=3094&rft.epage=3103&rft.pages=3094-3103&rft.issn=0009-7322&rft.eissn=1524-4539&rft.coden=CIRCAZ&rft_id=info:doi/10.1161/01.CIR.96.9.3094&rft_dat=%3Cproquest_cross%3E79439540%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=212722314&rft_id=info:pmid/9386180&rfr_iscdi=true |